Elevance Health ROE 2010-2024 | ELV
Current and historical return on equity (ROE) values for Elevance Health (ELV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Elevance Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $6.42B | $43.88B | 15.44% |
| 2024-06-30 | $6.69B | $42.30B | 16.63% |
| 2024-03-31 | $6.24B | $40.71B | 15.91% |
| 2023-12-31 | $5.99B | $39.41B | 15.58% |
| 2023-09-30 | $6.00B | $38.54B | 15.92% |
| 2023-06-30 | $6.31B | $38.31B | 17.04% |
| 2023-03-31 | $6.09B | $37.46B | 16.73% |
| 2022-12-31 | $5.89B | $36.33B | 16.34% |
| 2022-09-30 | $6.22B | $36.04B | 17.27% |
| 2022-06-30 | $6.13B | $35.87B | 17.04% |
| 2022-03-31 | $6.28B | $36.03B | 17.57% |
| 2021-12-31 | $6.16B | $36.13B | 17.48% |
| 2021-09-30 | $5.52B | $35.81B | 16.00% |
| 2021-06-30 | $4.23B | $35.05B | 12.44% |
| 2021-03-31 | $4.71B | $33.92B | 13.92% |
| 2020-12-31 | $4.57B | $33.20B | 13.72% |
| 2020-09-30 | $4.96B | $33.92B | 15.04% |
| 2020-06-30 | $5.92B | $34.46B | 18.31% |
| 2020-03-31 | $4.78B | $31.69B | 15.23% |
| 2019-12-31 | $4.81B | $31.73B | 15.53% |
| 2019-09-30 | $4.30B | $31.33B | 14.24% |
| 2019-06-30 | $4.07B | $30.79B | 13.76% |
| 2019-03-31 | $3.99B | $30.00B | 13.71% |
| 2018-12-31 | $3.75B | $28.54B | 13.23% |
| 2018-09-30 | $4.56B | $29.09B | 16.37% |
| 2018-06-30 | $4.34B | $28.73B | 16.06% |
| 2018-03-31 | $4.15B | $27.01B | 15.66% |
| 2017-12-31 | $3.84B | $26.50B | 14.64% |
| 2017-09-30 | $2.98B | $25.95B | 11.51% |
| 2017-06-30 | $2.85B | $26.43B | 11.14% |
| 2017-03-31 | $2.78B | $26.09B | 11.09% |
| 2016-12-31 | $2.47B | $25.10B | 10.12% |
| 2016-09-30 | $2.28B | $24.74B | 9.56% |
| 2016-06-30 | $2.32B | $24.23B | 9.87% |
| 2016-03-31 | $2.40B | $23.55B | 10.33% |
| 2015-12-31 | $2.56B | $23.04B | 10.93% |
| 2015-09-30 | $2.89B | $23.24B | 12.17% |
| 2015-06-30 | $2.86B | $23.06B | 11.93% |
| 2015-03-31 | $2.73B | $24.33B | 11.24% |
| 2014-12-31 | $2.57B | $24.25B | 10.57% |
| 2014-09-30 | $2.21B | $24.29B | 9.04% |
| 2014-06-30 | $2.24B | $24.38B | 9.10% |
| 2014-03-31 | $2.31B | $24.35B | 9.37% |
| 2013-12-31 | $2.49B | $24.77B | 10.12% |
| 2013-09-30 | $2.81B | $24.81B | 11.51% |
| 2013-06-30 | $2.84B | $24.53B | 11.78% |
| 2013-03-31 | $2.68B | $24.32B | 11.23% |
| 2012-12-31 | $2.66B | $23.80B | 11.21% |
| 2012-09-30 | $2.53B | $23.82B | 10.72% |
| 2012-06-30 | $2.52B | $23.64B | 10.70% |
| 2012-03-31 | $2.58B | $23.53B | 10.88% |
| 2011-12-31 | $2.65B | $23.29B | 11.13% |
| 2011-09-30 | $2.86B | $23.72B | 11.96% |
| 2011-06-30 | $2.92B | $24.18B | 12.11% |
| 2011-03-31 | $2.94B | $23.98B | 12.24% |
| 2010-12-31 | $2.89B | $23.81B | 11.97% |
| 2010-09-30 | $5.08B | $24.36B | 20.83% |
| 2010-06-30 | $5.07B | $23.79B | 21.12% |
| 2010-03-31 | $5.04B | $24.52B | 21.35% |
| 2009-12-31 | $4.75B | $24.86B | 20.75% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $96.890B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |